Brief: Adaptive Biotechnologies Q3 EPS USD -0.35
09/11/2023 21:05
Nov 09 (Reuters) - Adaptive Biotechnologies Q3 net income USD -50.326 million. * Q3 operating expenses USD 88.875 million * Q3 operating income USD -50.956 million * Q3 revenue USD 37.919 million vs. IBES estimate USD 43 million * Q3 adjusted EBITDA USD -29.8 million * outlook FY revenue USD 100-105 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates